Bile acid‐activated receptors in innate and adaptive immunity: targeted drugs and biological agents
European Journal of Immunology · 2023
DOI: 10.1002/eji.202250299 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Immunology, 2023. Verfasst von Kenneth C P Cheung und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hong Kong Phenome Research Center, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China. Hauptthemen laut MEDLINE: Immunity, Innate, Bile Acids and Salts, Adaptive Immunity, Receptors, G-Protein-Coupled. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HKBU Strategic Development Fund, France/Hong Kong Joint Research Scheme, RC's Startup Grant (Tier 1).
Abstract (Originalsprache)
Bile acid‐activated receptors (BARs) such as a G‐protein bile acid receptor 1 and the farnesol X receptor are activated by bile acids (BAs) and have been implicated in the regulation of microbiota‐host immunity in the intestine. The mechanistic roles of these receptors in immune signaling suggest that they may also influence the development of metabolic disorders. In this perspective, we provide a summary of recent literature describing the main regulatory pathways and mechanisms of BARs and how they affect both innate and adaptive immune system, cell proliferation, and signaling in the context of inflammatory diseases. We also discuss new approaches for therapy and summarize clinical projects on BAs for the treatment of diseases. In parallel, some drugs that are classically used for other therapeutic purposes and BAR activity have recently been proposed as regulators of immune cells phenotype. Another strategy consists of using specific strains of gut bacteria to regulate BA production in the intestine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hong Kong Phenome Research Center, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China.
- Oroxcell, Parc Biocitech, Romainville, France.
- Center for Translational Medicine and Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
ORCID-Profile: Kenneth C P Cheung
Förderung
- HKBU Strategic Development Fund
- France/Hong Kong Joint Research Scheme
- RC's Startup Grant (Tier 1)
Zitieren
APA
Cheung, K. C. P., Ma, J., Loiola, R. A., Chen, X., & Jia, W. (2023). Bile acid‐activated receptors in innate and adaptive immunity: targeted drugs and biological agents. European Journal of Immunology. https://doi.org/10.1002/eji.202250299
Vancouver
Cheung KCP, Ma J, Loiola RA, Chen X, Jia W. Bile acid‐activated receptors in innate and adaptive immunity: targeted drugs and biological agents. European Journal of Immunology. 2023. doi:10.1002/eji.202250299
BibTeX
@article{Cheung2023,
author = {Cheung, Kenneth C P and Ma, Jiao and Loiola, Rodrigo Azevedo and Chen, Xingxuan and Jia, Wei},
title = {Bile acid‐activated receptors in innate and adaptive immunity: targeted drugs and biological agents},
journal = {European Journal of Immunology},
year = {2023},
doi = {10.1002/eji.202250299}
}
EUVIMED